14-day Premium Trial Subscription Sign Up For FreeGet Free

Stock Market Week 20 - The Game Is On! Click to watch.

AcelRx Pharmaceuticals Stock Forecast

NASDAQ:ACRX BUY SELL

$0.21 (-0.14%)

Volume: 667.786k

Closed: May 16, 2022

Hollow Logo Score: -2.635

AcelRx Pharmaceuticals Stock Forecast

BUY SELL NASDAQ:ACRX
$0.21 (-0.14%)

Volume: 667.786k

Closed: May 16, 2022

Score Hollow Logo -2.635

AcelRx Pharmaceuticals Stock Forecast NASDAQ:ACRX

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-03-14 - HC Wainwright & Co. - Downgrades Buy Neutral
2021-08-17 2280.95% HC Wainwright & Co. $7.00 $5.00 Maintains Buy
2020-08-13 300% Credit Suisse $0.69 $0.84 Maintains Underperform
2020-07-20 228.57% Credit Suisse $1.00 $0.69 Downgrades Neutral Underperform
2020-03-17 3233.33% HC Wainwright & Co. $9.00 $7.00 Maintains Buy
2019-11-11 852.38% Credit Suisse $7.00 $2.00 Downgrades Outperform Neutral
2019-08-05 3233.33% Credit Suisse $7.00 Assumes Outperform
2019-07-10 - Credit Suisse - Assumes Outperform

ACRX Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -46.44% during the next 3 months and, with a 90% probability hold a price between $0.0915 and $0.14 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-18 $0.17 $0.21 $0.26
2022-05-19 $0.16 $0.21 $0.25
2022-05-20 $0.16 $0.21 $0.25
2022-05-23 $0.16 $0.20 $0.25
2022-05-24 $0.15 $0.20 $0.24
2022-05-25 $0.15 $0.19 $0.24
2022-05-26 $0.14 $0.19 $0.24
2022-05-27 $0.14 $0.19 $0.23
2022-05-31 $0.14 $0.18 $0.23
2022-06-01 $0.13 $0.18 $0.22
2022-06-02 $0.13 $0.17 $0.22
2022-06-03 $0.13 $0.17 $0.22
2022-06-06 $0.12 $0.17 $0.21
2022-06-07 $0.12 $0.16 $0.21
2022-06-08 $0.11 $0.16 $0.21
2022-06-09 $0.11 $0.16 $0.20
2022-06-10 $0.11 $0.15 $0.20
2022-06-13 $0.10 $0.15 $0.19
2022-06-14 $0.0989 $0.14 $0.19
2022-06-15 $0.0951 $0.14 $0.19
2022-06-16 $0.0913 $0.14 $0.18
2022-06-17 $0.0875 $0.13 $0.18
2022-06-21 $0.0837 $0.13 $0.17
2022-06-22 $0.0800 $0.13 $0.17
2022-06-23 $0.0762 $0.12 $0.17
2022-06-24 $0.0724 $0.12 $0.16
2022-06-27 $0.0686 $0.11 $0.16
2022-06-28 $0.0648 $0.11 $0.16
2022-06-29 $0.0610 $0.11 $0.15
2022-06-30 $0.0572 $0.10 $0.15

About AcelRx Pharmaceuticals

AcelRx Pharmaceuticals AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain in the United States. The company’s lead product candidates include ARX-04, a sufentanil sublingual tablet that is in Phase III clinical trials for the treatment of moderate-to-severe acute pain to be administered by a healthcare professional to a patient in medically supervised settings; and Zalviso, a sufentan... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT